|
Register for the 27th Pharma & Med Device Ethics & Compliance Congress by July 17 for Early Bird Rates
|
- A Hybrid Onsite Conference and Internet Event
- The Leading Forum on Pharmaceutical and Medical Device Ethics and Compliance Issues
- Sponsored by Pharmaceutical Compliance Forum
- October 13-16, 2026
- Washington Hilton, Washington, DC
- www.PharmaCongress.com
PRESS RELEASE
Phone: 800-503-7419
Email: reginfo@hcconferences.com
Website: www.PharmaCongress.com
|
|
EARLY BIRD REGISTRATION
|
Register by July 17 for Early Bird
Click here to register individuals or groups.
|
|
AGENDA-AT-A-GLANCE
|
|
Click here for Agenda-at-a-Glance.
|
|
EXHIBIT & SPONSORSHIP OPPORTUNITIES
|
|
Click here for promotional opportunities.
|
|
|
WASHINGTON, DC USA -- PHARMA UPDATE NEWS SERVICE™ -- JUNE 23, 2025: The Twenty-Seventh Annual Pharmaceutical & Medical Device Ethics and Compliance Congress sponsored by the Pharmaceutical Compliance Forum (PCF) will be held at the Washington Hilton, Washington, DC on October 13-16, 2026. Attendees may attend either virtually online or in person. Onsite attendees will also enjoy both live and post-conference access to the Congress audio/video archive.
|
|
THE 2026 27TH ANNUAL CONGRESS FEATURES
|
- New half-day specialty summits on the afternoon of Tuesday 10/13
- Over 50 concurrent mini summits and 15 plenary session presentations
- The PCF-sponsored, Closed-door, invitation-only CCO Roundtable, last year attended by over 100 CCOs
- The Industry-only Compliance Best Practices Think Tank hosted by PCF
- A sold-out exhibit hall featuring many innovative ethics and compliance products, programs and initiatives
- Numerous professional networking opportunities
|
FEATURED ETHICS & COMPLIANCE PROFESSIONALS
AND IN-HOUSE COUNSEL
|
Peter Agnoletto, CPA
Compliance Officer, General Medicines and Consumer Health Care, Sanofi; Former Senior Director & CCO, Par Pharma, Bridgewater, NJ |
Kaoutar Afif
Manager, Ethics & Compliance, Cardinal Health, New York, NY |
Peter Brensilver, JD, MPH
Senior Vice President, Chief Global Commercial Compliance & Risk Counsel, Pfizer, New York, NY
|
Terra Buckley, JD
Chief Compliance & Ethics Officer, Bristol Myers Squibb; Former CCO, LivaNova, Summit, NJ |
Briana Cabrera, MS, CFE
Senior Director, Global Privacy & Compliance Investigations, Medtronic; Former Director, Forensic Audit, Covidien, Miami, FL |
Regina Cavaliere, JD
Chief Ethics & Compliance Officer, VP Regulatory & Compliance, Henry Schein, Melville, NY
|
Kevin Espinoza, MBA
Chief Integrity & Compliance Officer, Indivior; Former Chief Integrity & Compliance Officer, Kaleo; Former Senior VP, Boston Scientific, Richmond, VA |
Yelena Ferreira, JD
Assistant GC & Head of Compliance, Pharmacosmos; Former Senior Director, Associate General Counsel, Pacira, Morristown, NJ |
Lindsey LaMoria Gavin
Senior Director, Deputy Compliance Officer, Lundbeck; Former Compliance Director, Meetings & Events International, Deerfield, IL
|
Kate Godfrey, JD, CCEP
Senior VP, Global Chief Compliance Officer, Chief Compliance Officer KSNA, Karl Storz North America, El Segundo, CA |
Abe Kassis, MBA, PhD
Global Head Compliance & Legal Operations, Bausch + Lomb; Former Global Compliance Director, Takeda, New York, NY |
Jeffrey Kawalek, MBA
Chief Compliance Officer, Zambon US; Former Deputy CCO US, Jazz; Former Co-chair, PCF, New York, NY
|
Cheryl Lee, MBA, CHC
Head of Compliance, Cycle; Former VP, ESG Strategy & Execution, BMS; Former VP, Head of Compliance Worldwide Markets, Celgene, New York, NY |
Peter Lee, JD, LLM
Chief Compliance Officer, Kura Oncology; Former CCO, Mirati Therapeutics; Former CCO, Heron Therapeutics, San Diego, CA |
Aaron Lewis, MBA
Director, Legal and Compliance Operations, Cordis; Former Director, Compliance Insights and Technologies, Cardinal Health, Miami Lakes, FL
|
Melissa T. Lozner, JD
Senior VP, CCO, Regeneron; Former Chief Compliance & Ethics Officer, Rafael Holdings; Former VP, Head of Ethics, Risk & Compliance, Novartis, Tarrytown, NY |
Rosemary McKenna, JD
Executive Director, Regulatory Legal, Organon; Former Director, Regulatory-Legal, Merck, Philadelphia, PA |
Joan Podleski, CCEP, CHPC, CHRC, CHC
VP & CPO, Children's Health System of Texas; Former Director, Institutional Ethics & Compliance Program, Duke University, Dallas, TX
|
Ariadna Quesada, MSJ
VP, Compliance, Global Compliance & Privacy lead, ZOLL Medical; Former Compliance Director, Europe & MEATI, Hillrom, Madrid, Spain |
R. Brett Short, CHC, CHPC, CHRC
CCO & CPO, University of Kentucky; Immediate Past Chair, Health Care Compliance Association, Lexington, KY |
Jesse Siegel, JD
Head of Business Ethics, Americas, Ipsen; Former Senior Counsel, Neurology & Immunology, EMD Serono, Cambridge, MA
|
Ronald Strauss, CIPM
Vice President Compliance, MiMedx; Former Executive Sales Representative, Eli Lilly Specialty, Marietta, GA |
Betsy Wade, MPH, CHC, CHPC, CAN
Chief Compliance & Ethics Officer, Signature Healthcare; Board & Treasurer, Health Care Compliance Association, Louisville, KY |
Kelly Willenberg, MBA, DBA, CHC, CHRC
Chief Executive Officer, Kelly Willenberg & Assocs.; Board & Second Vice Chair, Health Care Compliance Association, Greenville, SC
|
Elizabeth Weiss, JD
VP, Chief Compliance & Privacy Officer, Invivyd; Former Head of Compliance for Americas & EMEA, Lupin; Former Assistant GC, Compliance Lead, Global Health & Patient Access, Pfizer, Livingston, NJ |
Amy Wilson, MBA, MSJ
VP & CCO, Esperion; Former Head of US Compliance, MorphoSys; Former Director, Enterprise Compliance, Alexion, Boston, MA
|
Suki Wiltman
Vice President, Global Ethics & Compliance, Ipsen; Former Business Partner, Governance, Ethics & Compliance, GSK; Former Sr Corporate Compliance Manager, Allergan Canada, Toronto, Canada |
Stacy E. Yeung, JD
VP & GC, SELLAS; Former Assistant General Counsel, Arena Pharmaceuticals; Former Deputy General Counsel, DBV Technologies, New York, NY
|
|
FORMER GOVERNMENT OFFICIALS
|
Corey R. Amundson, JD
Partner, King & Spalding; Former Head, Public Integrity Section, US DOJ; Former Acting US Attorney, Middle District of Louisiana, Washington, DC |
Jennifer L. Bragg, JD
Partner, Latham and Watkins; Former Associate Chief Counsel for Enforcement, Office of Chief Counsel, US FDA, Washington, DC |
Hui Chen, JD
Co-Founder, Culture. Data. Ethics; Former Compliance Counsel Expert, US DOJ; Former Assistant General Counsel, Pfizer, Honolulu, HI
|
Deborah A. Curtis, JD
Partner, Arnold & Porter; Former Deputy GC, CIA; Former Deputy Chief, Counterespionage, US DOJ, Washington, DC |
John Delacourt, JD
Deputy GC, VP Health, Regulatory & Commercial Operations, BIO; Former Chief Antitrust Counsel, FTC, Washington, DC |
Greg Demske, JD
Partner, Goodwin Procter; Former Chief Counsel, Office of Inspector General, US HHS, Washington, DC
|
Sarah A. Franklin, JD
Partner and Vice-Chair, Life Sciences Investigations Practice, Covington & Burling; Former Attorney, US FTC, Washington, DC |
Gejaa T. Gobena, JD
Partner, Hogan Lovells; Former Deputy Chief, Fraud Section, Criminal Division, US Department of Justice, Washington, DC |
John Kelly, JD
Partner & Chair, Healthcare Practice, Barnes & Thornburg; Former Asst. Chief for Health Care Fraud, Criminal Division, US DOJ, Washington, DC
|
Barbara A. Leaf, JD
Senior International Policy Advisor, Arnold & Porter; Former Special Assistant to the President; Former US Ambassador, UAE, Washington, DC |
Christine Moundas, JD, MPH
Healthcare & Data Partner & Co-Head, Digital Health Initiative, Ropes & Gray; Former Analyst, Office of Inspector General, US HHS, New York, NY |
Ida Nassar, JD
Vice President, Assistant General Counsel, Ethics & Compliance, AdvaMed; Former Senior Attorney, Office of Chief Counsel, US Drug Enforcement Administration, Washington, DC
|
Diane Seol, JD
Of Counsel, Choate Hall & Stewart; Former Assistant United States Attorney, Affirmative Civil Enforcement Unit, US Attorney's Office, District of Massachusetts, Boston, MA |
Michael L. Shaw, JD
Global Head of Compliance, Privacy and Risk, ZS; Former VP & CO, GlaxoSmithKline; Former Senior Counsel, OIG US HHS, Princeton, NJ
|
Amanda Strachan, JD
Partner, WilmerHale; Former AUSA & Chief, Criminal Division, US Attorney's Office, District of Massachusetts, US DOJ, Boston, MA |
Jane H. Yoon, JD
Partner, Litigation Department, Paul Hastings; Former Assistant United States Attorney, US Attorney's Office, New Jersey, New York, NY
|
|
OTHER FEATURED FACULTY
|
Eliza L. Andonova, JD
Partner, Global Regulatory, Hogan Lovells, Washington, DC |
Brett Barlag, MBA
Senior Managing Director, Healthcare Risk Management and Advisory, FTI Consulting, New York, NY |
Samantha Barrett Badlam, JD
Partner, Litigation & Enforcement Group, Ropes & Gray, Washington, DC
|
Yogesh Bahl, MBA
Practice Leader, Resolution Life Sciences; CFO & Head of Investor Relations, IACTA, New York, NY |
Craig B. Bleifer, JD
Partner, McGuire Woods; Former Corporate VP, GC North America; Novo Nordisk, New York, NY |
Eric Bolesh
Chief Operating Officer, Cutting Edge Information, Research Triangle Park, NC
|
Jennifer Ceglinski, JD, CFE
Manager, Forensic & Integrity Services, EY, Charlotte, NC |
Michael Clarke, JD, CCEP, NACD.DC®
Principal, Jaeger-Plymouth; Retired VP, Deputy GC & Global CCO, ConvaTec; Former VP, Compliance, Indivior, Bridgewater, NJ |
Chris Cobourn, MS
Managing Director, Government Programs Practice Lead, Helio Health Group, Placida, FL
|
Benjamin Correa, JD
Partner, Food, Drug & Medical Device, Sidley Austin, Washington, DC |
Zachary Coseglia, JD
Co-Founder, Culture. Data. Ethics; Former VP & AGC, Monitoring, Analytics and Digital, Pfizer, Boston, MA |
Layla Covington, JD
Senior Manager, Compliance Consulting, Cresen; Former Manager, Aggregate Spend, Genentech, Chicago, IL
|
Clarissa Crain
Managing Director, Deloitte, Phoenixville, PA |
Meena Datta, JD
Partner and Global Co-leader, Healthcare Practice, Sidley Austin, Chicago, IL |
Mahnu V. Davar, MA, JD
Partner and Co-chair, Life Sciences & Healthcare Regulatory, Arnold & Porter, Washington, DC
|
Stefanie A. Doebler, JD
Partner and Co-Chair, Health Care Practice Group, Covington & Burling, Washington, DC |
Kip Ebel, MBA
Principal, Forensic & Integrity Services, EY, New York, NY |
Aurelie Ercoli, LLM, PhD
Partner, Life Sciences Practice Group, DLA Piper, US, Washington, DC
|
Ronnie H. Feldman
Founder & CEO, L&E: Comedians Who Improve Compliance, Chicago, IL |
Alison J. Fethke, JD
Member of the Firm, Epstein Becker Green; Former Division Counsel, Legal Regulatory & Compliance, AbbVie, Chicago, IL |
David Fisher, MS
President, TDI Solutions; Former VP & General Manager, Cyber Innovations, Battelle, Washington, DC
|
Sara K. Frank, JD
Principal, Life Science Practice, Choate Hall & Stewart, Boston, MA |
Gary F. Giampetruzzi, JD
Partner & Global Chair Life Sciences, Paul Hastings; Former VP & AGC, Head of Government Investigations, Pfizer, New York, NY |
John Gitas, MBA
Principal, US Advisory, Healthcare and Life Sciences, KPMG, New York, NY
|
Noah C. Goldstein, JD
Counsel, Porzio Bromberg & Newman; Former Compliance and Privacy Specialist, Beth Israel Deaconess Medical Center, Westborough, MA |
Neeraj Gupta, MBA
President, Chief Technology Officer, Cresen Solutions, Chester Springs, PA |
Kris Hall, JD, CIPP/CIPM
Managing Director, Dovetail; Former VP, Chief Privacy Officer, Celgene; Former VP, Head of Privacy, Shire, Bridgton, ME
|
Kristin M. Hicks, JD
Partner, Arnold & Porter, Washington, DC |
Emily F. Hodge, JD
Partner, Life Science Practice, Choate, Hall & Stewart, Boston, MA |
Casey J. Horton, CFE
Managing Director, Epsilon Life Sciences; Former Director, Compliance Operations, AbbVie, Chicago, IL
|
Jeff Hyre
Vice President Sales, Healthcare & Life Sciences, Global Relay, Denver, CO |
Katie Jacyna
Vice President, Product Management, Helio Health Group, Denver, CO |
Mark A. Jensen, JD
Partner, Special Matters and Government Investigations, King & Spalding, Washington, DC
|
Erin Brown Jones, MA, JD
Partner, Latham & Watkins, Washington, DC |
Marci Juneau, MBA
A Founding Partner, Helio Health Group, Atlanta, GA |
Olivia Krzeminski, JD
Director of Compliance & Legal Research, G&M Health, Somerset, NJ
|
Jeffrey Low, RPh, MHA
Director, Ankura; Former VP, Clinical Services, Magellan Health; Former Director, Medicare Services, CVS/Caremark, Phoenix, AZ |
Robert Melillo, JD
Co-founder and Managing Director, G&M Health, Cocoa Beach, FL |
Brook Mishler, RN, MSN
Global Director of Compliance Solutions, Life Sciences, Case IQ; Former Compliance Officer for the Americas, Cordis, Ontario, Canada
|
|
|
|
SPONSORED BY
|
|
|
PRODUCED BY
|
|
|
PCF BOARD
|
Donna White, CCEP
Vice President and Compliance Officer, Chiesi Farmaceutici S.p.A., Americas Region (Board Chair)
Christie Camelio
Senior Vice President and Chief Compliance Officer, Insmed
Jill Dailey, JD
Vice President & Chief Compliance Officer, Oncology, Menarini Stemline
Anisa Dhalla
Vice President, Global Head, Ethics and Business Integrity, UCB
Daryl Kreml, JD
Head of Ethics & Compliance, Global Oncology, Takeda
Melissa T. Lozner, JD
Senior Vice President, Chief Compliance Officer, Regeneron
|
|
MEDICAL DEVICE EXECUTIVE COMMITTEE
|
Sujata Dayal, JD
Independent Board Director, Emergent BioSolutions; Senior Advisor
JJ Kuhn, JD
Senior Vice President and Chief Ethics & Compliance Officer, Solventum
Mona Peterson Rosow, JD, MPH
Vice President, Global Risk, Ethics & Compliance Officer, Mozarc Medical
Tara Shewchuk, JD, LLM
Senior Vice President, Chief Privacy, Integrity & Compliance Officer, Medtronic
Daniel Spicehandler, JD
Vice President Compliance, Commercial Divisions, Stryker
|
|
MEDIA PARTNERS
|
|
|
GRANTORS
|
|
PLATINUM
|
|
|
GOLD
|
|
|
SILVER
|
|
|
BRONZE
|
|
|
EXHIBITOR
|
|
|
Katherine C. Norris, MPA
Senior Managing Director, Life Sciences Compliance, Disputes & Economics, Ankura, Honolulu, HI |
Daniel O'Connor
Senior Vice President, NXLevel Compliance; Angel Investor, Angel Investor Forum, Lambertville, NJ |
John Poulin
Chief Technology Officer and Partner, Helio Health Group, Boston, MA |
Saraswatha Lalitha Putcha, MA
Director, Product & Client Delivery, Cresen Solutions, Philadelphia, PA |
Nikki Reeves, JD
Partner and Co-chair, Life Sciences and Healthcare Industry Group, King & Spalding, Washington, DC
|
Russell Rose, JD
Managing Director, Life Sciences Advisory, Deloitte, Dallas, TX |
Jeffrey Scott, JD
Of Counsel, Life Sciences, DLA Piper; Former Lead Compliance Counsel, Digital, Reporting, and Analytics, Pfizer, Philadelphia, PA |
Paul Silver
Principal, Life Sciences Regulatory, Legal & Compliance Leader, Deloitte, Atlanta, GA |
Laura A. Skinner, MBA
Managing Director, Life Sciences & Healthcare Consulting Group, Paul Hastings; Managing Director, Rare Disease Compliance Consortium, New York, NY |
Ravneet Talwar, MBA
Senior Manager, Life Sciences & Healthcare Consulting Group, Paul Hastings, New York, NY
|
L. Stephan Vincze, JD, LLM, MBA
President & CEO, TRESTLE Compliance; Former SVP & CCO, Warner Chilcot; Former VP & CCO, TAP, Boston, MA |
Erin Wagenberg, CIPP/US, CIPP/E, CIPT, FIP
Director, Dovetail Consulting Group; Former Deputy Privacy Officer, Deloitte Global, Atlanta, GA |
Shannon Walker
Executive Vice President, Thought Leadership & Strategy, Case IQ; Founder and President, Whistleblower Security, Ontario, Canada |
Robert A. Wells, JD
Shareholder, Baker Donelson, Baltimore, MD |
Kelly Willenberg, MBA, DBA, CHC
Chief Executive Officer, Kelly Willenberg and Associates, Greenville, SC
|
Jacob Wolf, MBA
Chief Commercial Officer, Cresen Solutions, Orlando, FL |
Cobun Zweifel-Keegan, JD, CIPP/US
Managing Director, IAPP; Former Deputy Director, Privacy Initiatives, Better Business Bureau, Washington, DC
|
|
THE PHARMA CONGRESS ANNOUNCES AN EXTRA AFTERNOON OR HALF-DAY SPECIALTY FOCUSED SESSIONS ON HIT ISSUES IN PHARMA & DEVICE COMPLIANCE!
|
|
Kick off 27th Pharma/Device Ethics & Compliance Congress with an added half-day of high-impact Specialty Sessions on Tuesday afternoon, October 13, featuring timely, expert-led deep dives on the hottest issues facing pharma and device companies today. These will include sessions on Advanced Strategies Coordinating Compliance between Medial Affairs and Commercial & Practical Case Studies in the Use of AI by Pharma and Device Company Ethics and Compliance Departments. Included with your registration, this is a valuable opportunity to gain practical insights, benchmark with peers, and arrive fully prepared for the main three-day event.
|
|
AN OVERVIEW OF THE 27TH CONGRESS SCHEDULE
|
Day 1: Tuesday, October 13,2026
- Afternoon Half-day Specialty Focused Sessions
Day 2: Wednesday, October 14,2026
- Networking Breakfast
- Morning Concurrent Mini Summits
- Networking Luncheon
- Afternoon Opening Plenary Session
- Networking Reception
Day 3: Thursday, October 15,2026
- Networking Breakfast
- Morning PCF CCO Roundtable (Invitation-only)
- Morning Concurrent Mini Summits
- Networking Luncheon
- Afternoon Closing Plenary Session
Day 4: Friday, October 16,2026
- Networking Breakfast
- Morning PCF Industry-only Plenary Session
- Noon: Congress Adjournment
|
|
FOR E-MAIL ADDRESS CHANGE, ADD OR DELETE REQUESTS
|
For changes or additions, please email your request to: listmgr@PharmaUpdateNewsService.com.
For removal of your e-mail address, please click the link below for "SafeUnsubscribe" to automatically remove your address from the list.
|
|
|
|
